ISRAEL – The Israel Patent Office, affiliated with the Israeli Ministry of Justice, has approved NLS Pharmaceutics Ltd.’s Mazindol as a method of treatment for Attention Deficit/Hyperactivity Disorder (ADHD). NLS…
Read MoreTag: Drug development
AUDA-NEPAD explores path to implement the Pharmaceutical Manufacturing plan for Africa
AFRICA – The African Union Development Agency-NEPAD (AUDA-NEPAD) has outlined comprehensive strategies to develop and implement the Pharmaceutical Manufacturing plan for Africa (PMPA) with support of relevant partners. The mandate…
Read MoreUgandans launch drive to raise US$10M funds for manufacturing local cancer and diabetes drug
UGANDA- Notable Ugandans have deployed a drive to raise UGX35.2B (US$10M) in support of the development of local cancer and diabetes drug. The influential personalities joined efforts with David Ssenfuka,…
Read MoreRoche to reexamine Huntington’s disease drug
SWITZERLAND – Roche has outlined a new clinical path forward for tominersen, a closely watched Huntington’s disease drug, ten months after disappointing Phase 3 study results appeared to spell the…
Read MoreLilly, Evotec partner to develop drugs for metabolic diseases
USA – Eli Lilly and Company has announced a drug discovery collaboration with Evotec in the field of metabolic diseases, with a focus on kidney diseases and diabetes. The three-year…
Read MoreNovartis inches closer to selling generic drug unit, Sandoz for US$21 billion: Report
SWITZERLAND – According to a German newspaper, Handelsblatt, the Swedish-based investment group EQT and the German Struengmann family are considering a joint bid for Novartis AG’s generics unit, Sandoz, for…
Read MoreGilead Sciences, Merck kick off phase 2 islatravir/lenacapavir HIV study
USA – Gilead Sciences, and Merck have announced the start of a Phase 2 clinical study evaluating an investigational once-weekly oral combination treatment regimen of islatravir and lenacapavir in HIV…
Read More